• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

共价相互作用抑制剂的合理设计方案。

Protocol for rational design of covalently interacting inhibitors.

作者信息

Schmidt Thomas C, Welker Armin, Rieger Max, Sahu Prabhat K, Sotriffer Christoph A, Schirmeister Tanja, Engels Bernd

机构信息

Institut für Physikalische und Theoretische Chemie, Julius-Maximilians-Universität Würzburg, Würzburg (Germany).

出版信息

Chemphyschem. 2014 Oct 20;15(15):3226-35. doi: 10.1002/cphc.201402542. Epub 2014 Sep 24.

DOI:10.1002/cphc.201402542
PMID:25251382
Abstract

The inhibition potencies of covalent inhibitors mainly result from the formation of a covalent bond to the enzyme during the inhibition mechanism. This class of inhibitors has essentially been ignored in previous target-directed drug discovery projects because of concerns about possible side effects. However, their advantages, such as higher binding energies and longer drug-target residence times moved them into the focus of recent investigations. While the rational design of non-covalent inhibitors became standard the corresponding design of covalent inhibitors is still in its early stages. Potent covalent inhibitors can be retrieved from large compound libraries by covalent docking approaches but protocols are missing that can reliably predict the influence of variations in the substitution pattern on the affinity and/or reactivity of a given covalent inhibitor. Hence, the wanted property profile can only be obtained from trial-and-error proceedings. This paper presents an appropriate protocol which is able to predict improved covalent inhibitors. It uses hybrid approaches, which mix quantum mechanical (QM) and molecular mechanical (MM) methods to predict variations in the reactivity of the inhibitor. They are also used to compute the required information about the non-covalent enzyme-inhibitor complex. Docking tools are employed to improve the inhibitor with respect to the non-covalent interactions formed in the binding site.

摘要

共价抑制剂的抑制效力主要源于在抑制机制过程中与酶形成共价键。由于担心可能的副作用,这类抑制剂在以往的靶向药物发现项目中基本上被忽视了。然而,它们的优势,如更高的结合能和更长的药物 - 靶点驻留时间,使其成为近期研究的焦点。虽然非共价抑制剂的合理设计已成为标准,但共价抑制剂的相应设计仍处于早期阶段。可以通过共价对接方法从大型化合物库中检索出强效共价抑制剂,但缺少能够可靠预测取代模式变化对给定共价抑制剂亲和力和/或反应性影响的方案。因此,理想的性质概况只能通过反复试验的过程来获得。本文提出了一种能够预测改进的共价抑制剂的合适方案。它使用混合方法,将量子力学(QM)和分子力学(MM)方法结合起来预测抑制剂反应性的变化。这些方法还用于计算有关非共价酶 - 抑制剂复合物的所需信息。对接工具用于针对结合位点中形成的非共价相互作用来优化抑制剂。

相似文献

1
Protocol for rational design of covalently interacting inhibitors.共价相互作用抑制剂的合理设计方案。
Chemphyschem. 2014 Oct 20;15(15):3226-35. doi: 10.1002/cphc.201402542. Epub 2014 Sep 24.
2
Covalent simulations of covalent/irreversible enzyme inhibition in drug discovery: a reliable technical protocol.共价模拟在药物研发中对共价/不可逆酶抑制的应用:一种可靠的技术方案。
Future Med Chem. 2018 Oct;10(19):2265-2275. doi: 10.4155/fmc-2017-0304.
3
EMBM - a new enzyme mechanism-based method for rational design of chemical sites of covalent inhibitors.EMBM-一种基于酶机制的新方法,用于合理设计共价抑制剂的化学位点。
J Chem Inf Model. 2010 Dec 27;50(12):2256-65. doi: 10.1021/ci100330y. Epub 2010 Nov 19.
4
Comparative studies on inhibitors of HIV protease: a target for drug design.HIV蛋白酶抑制剂的比较研究:药物设计的一个靶点
In Silico Biol. 2008;8(5-6):427-47.
5
Promiscuity and selectivity in covalent enzyme inhibition: a systematic study of electrophilic fragments.共价酶抑制中的混杂性与选择性:亲电片段的系统研究
J Med Chem. 2014 Sep 25;57(18):7590-9. doi: 10.1021/jm5006918. Epub 2014 Sep 5.
6
Sourcing the affinity of flavonoids for the glycogen phosphorylase inhibitor site via crystallography, kinetics and QM/MM-PBSA binding studies: comparison of chrysin and flavopiridol.通过晶体学、动力学和量子力学/分子力学-泊松玻尔兹曼表面面积结合研究探寻黄酮类化合物对糖原磷酸化酶抑制剂位点的亲和力:白杨素与黄酮哌啶醇的比较
Food Chem Toxicol. 2013 Nov;61:14-27. doi: 10.1016/j.fct.2012.12.030. Epub 2012 Dec 29.
7
Docking covalent inhibitors: a parameter free approach to pose prediction and scoring.对接共价抑制剂:一种无参数的构象预测和评分方法。
J Chem Inf Model. 2014 Jul 28;54(7):1932-40. doi: 10.1021/ci500118s. Epub 2014 Jun 26.
8
Medicinal Chemistry Projects Requiring Imaginative Structure-Based Drug Design Methods.需要富有创意的基于结构的药物设计方法的药物化学项目。
Acc Chem Res. 2016 Sep 20;49(9):1646-57. doi: 10.1021/acs.accounts.6b00185. Epub 2016 Aug 16.
9
Inhibitors of FabI, an enzyme drug target in the bacterial fatty acid biosynthesis pathway.FabI抑制剂,一种细菌脂肪酸生物合成途径中的酶类药物靶点。
Acc Chem Res. 2008 Jan;41(1):11-20. doi: 10.1021/ar700156e.
10
Combined quantum mechanics/molecular mechanics (QM/MM) methods in computational enzymology.计算酶学中的量子力学/分子力学(QM/MM)联合方法。
Biochemistry. 2013 Apr 23;52(16):2708-28. doi: 10.1021/bi400215w. Epub 2013 Apr 12.

引用本文的文献

1
Exploring the Role of Chemical Reactions in the Selectivity of Tyrosine Kinase Inhibitors.探索化学反应在酪氨酸激酶抑制剂选择性中的作用。
J Am Chem Soc. 2022 Sep 14;144(36):16638-16646. doi: 10.1021/jacs.2c07307. Epub 2022 Aug 31.
2
Selective and Effective: Current Progress in Computational Structure-Based Drug Discovery of Targeted Covalent Inhibitors.选择性和有效性:基于结构的靶向共价抑制剂计算药物发现的当前进展。
Trends Pharmacol Sci. 2020 Dec;41(12):1038-1049. doi: 10.1016/j.tips.2020.10.005. Epub 2020 Nov 2.
3
Systematic Studies on the Protocol and Criteria for Selecting a Covalent Docking Tool.
系统研究选择共价对接工具的方案和标准。
Molecules. 2019 Jun 10;24(11):2183. doi: 10.3390/molecules24112183.
4
Structural and chemical insights into the covalent-allosteric inhibition of the protein kinase Akt.对蛋白激酶Akt共价变构抑制的结构与化学见解。
Chem Sci. 2019 Feb 13;10(12):3573-3585. doi: 10.1039/c8sc05212c. eCollection 2019 Mar 28.
5
Conformational flexibility of DENV NS2B/NS3pro: from the inhibitor effect to the serotype influence.登革病毒NS2B/NS3蛋白酶的构象灵活性:从抑制剂作用到血清型影响
J Comput Aided Mol Des. 2016 Mar;30(3):251-70. doi: 10.1007/s10822-016-9901-8. Epub 2016 Feb 29.
6
Docking Screens for Novel Ligands Conferring New Biology.用于赋予新生物学特性的新型配体的对接筛选
J Med Chem. 2016 May 12;59(9):4103-20. doi: 10.1021/acs.jmedchem.5b02008. Epub 2016 Mar 15.